1) Deferoxamine
去铁胺
1.
Deferoxamine protects against amikacin ototoxicity and ist mechanism;
甲磺酸去铁胺抗丁胺卡那霉素耳毒性作用及机理研究
2.
Objective To observe the change of mitochondrion membrane potential(ΔΨm) in apoptosis induced by an iron chelator(deferoxamine,DFO),and to explore the mechanism of this apoptosis in human leukemia-60(HL-60) cells.
方法HL-60细胞分别与10、50、100μmol/L去铁胺(DFO)和10、100μmol/L三氯化铁(FeCl3)共培养,分别造成细胞内铁剥夺和富铁状态,噻唑蓝(MTT)法检测不同铁状态下细胞活力变化;相差显微镜观察凋亡细胞的形态学改变,流式细胞仪(FCM)检测细胞凋亡率及ΔΨm变化;原位杂交法检测凋亡基因Bax转录水平。
3.
This study was purposed to observe the changes of caspase-3 activity during apoptosis of HL-60 cells induced by an iron chelator, DFO (deferoxamine), and to explore the mechanism underlying apoptosis in HL-60 cells.
为了研究铁螯合剂—去铁胺(deferoxamine,DFO)诱导人白血病细胞株HL-60凋亡时半胱天冬酶-3(caspase-3)活性的变化并探讨DFO诱导凋亡的可能机制。
2) desferrioxamine
[,di:sferi'ɔksəmain]
去铁胺
1.
The Antiproliferative Effect of Desferrioxamine on K562 Cell and Its Influence on Cell Cycle;
去铁胺抗K562细胞的增殖作用及对细胞周期的影响
2.
Mechanism of desferrioxamine activity in EMMPRIN expression in macrophages and foam cells
铁离子螯合剂去铁胺上调巨噬细胞、泡沫细胞细胞外基质金属蛋白酶诱导因子表达的机制探讨
3.
Iron chelator desferrioxamine enhances EMMPRIN expression in THP-1-derived macrophages and foam cells
铁离子螯合剂去铁胺对巨噬细胞、泡沫细胞细胞外基质金属蛋白酶诱导因子表达的影响
3) DFO
去铁胺
1.
Methods HL-60 cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum which was treated with ferric chloride(FeCl3) or deferoxamine(DFO).
方法将FeCl3或去铁胺(Desferrioxamine,DFO)加入含有体积分数10%胎牛血清的RPMI-1640培养液中,使HL-60细胞处于缺铁或富铁的不同状态下培养。
2.
To observe the effect of DFO on iron metabolism in primary cultured rats cardiac myocytes.
观察去铁胺(DFO)对原代培养的心肌细胞铁代谢的影响,探讨DFO对心肌细胞铁代谢的影响机制。
4) deferoxamine(DFO)
去铁胺(DFO)
5) deferoxamine (DFO)
去铁胺，去铁敏
6) desferrioxamine (DFO)
去铁草酰胺
补充资料：去铁胺
分子式：C25H48N6O8
分子量：暂无
CAS号：70-51-9
性质：暂无
制备方法：暂无
用途：解毒药。
分子量：暂无
CAS号：70-51-9
性质：暂无
制备方法：暂无
用途：解毒药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条